Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cesar A Moran

Showing results (201-210 of 220) with videos related to

Pageof 22
Sort By:
Cancer|October 25, 2011
Histologic patterns and molecular characteristics of lung adenocarcinoma associated with clinical outcomeLuisa M Solis, Carmen Behrens, M Gabriela Raso, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 31, 2011
Computed tomography findings predicting invasiveness of thymomaEdith M Marom, Miguel A Milito, Cesar A Moran, et al.
The Annals of Thoracic Surgery|May 23, 2020
LKB1/STK11 Expression in Lung Adenocarcinoma and Associations With Patterns of RecurrenceKyle G Mitchell, Edwin R Parra, Jiexin Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2010
Nrf2 and Keap1 abnormalities in non-small cell lung carcinoma and association with clinicopathologic featuresLuisa M Solis, Carmen Behrens, Wenli Dong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 8, 2013
EZH2 protein expression associates with the early pathogenesis, tumor progression, and prognosis of non-small cell lung carcinomaCarmen Behrens, Luisa M Solis, Heather Lin, et al.
The Journal of Thoracic and Cardiovascular Surgery|July 22, 2009
Application of the revised lung cancer staging system (IASLC Staging Project) to a cancer center populationEdmund S Kassis, Ara A Vaporciyan, Stephen G Swisher, et al.
Clinical Lung Cancer|April 14, 2020
Agreement on Major Pathological Response in NSCLC Patients Receiving Neoadjuvant ChemotherapyAnnikka Weissferdt, Apar Pataer, Ara A Vaporciyan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 20, 2013
Validation of a proliferation-based expression signature as prognostic marker in early stage lung adenocarcinomaIgnacio I Wistuba, Carmen Behrens, Francesca Lombardi, et al.
Chest|May 29, 2020
Clinical and Genomic Characteristics of Small Cell Lung Cancer in Never Smokers: Results From a Retrospective Multicenter Cohort StudyAnish Thomas, Idrees Mian, Camille Tlemsani, et al.
Cancer Research|March 27, 2015
CDK2 Inhibition Causes Anaphase Catastrophe in Lung Cancer through the Centrosomal Protein CP110Shanhu Hu, Alexey V Danilov, Kristina Godek, et al.
Pageof 22

Showing results (201-210 of 220) with videos related to

Sort By:
Pageof 22
Cancer|October 25, 2011
Histologic patterns and molecular characteristics of lung adenocarcinoma associated with clinical outcomeLuisa M Solis, Carmen Behrens, M Gabriela Raso, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 31, 2011
Computed tomography findings predicting invasiveness of thymomaEdith M Marom, Miguel A Milito, Cesar A Moran, et al.
The Annals of Thoracic Surgery|May 23, 2020
LKB1/STK11 Expression in Lung Adenocarcinoma and Associations With Patterns of RecurrenceKyle G Mitchell, Edwin R Parra, Jiexin Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2010
Nrf2 and Keap1 abnormalities in non-small cell lung carcinoma and association with clinicopathologic featuresLuisa M Solis, Carmen Behrens, Wenli Dong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 8, 2013
EZH2 protein expression associates with the early pathogenesis, tumor progression, and prognosis of non-small cell lung carcinomaCarmen Behrens, Luisa M Solis, Heather Lin, et al.
The Journal of Thoracic and Cardiovascular Surgery|July 22, 2009
Application of the revised lung cancer staging system (IASLC Staging Project) to a cancer center populationEdmund S Kassis, Ara A Vaporciyan, Stephen G Swisher, et al.
Clinical Lung Cancer|April 14, 2020
Agreement on Major Pathological Response in NSCLC Patients Receiving Neoadjuvant ChemotherapyAnnikka Weissferdt, Apar Pataer, Ara A Vaporciyan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 20, 2013
Validation of a proliferation-based expression signature as prognostic marker in early stage lung adenocarcinomaIgnacio I Wistuba, Carmen Behrens, Francesca Lombardi, et al.
Chest|May 29, 2020
Clinical and Genomic Characteristics of Small Cell Lung Cancer in Never Smokers: Results From a Retrospective Multicenter Cohort StudyAnish Thomas, Idrees Mian, Camille Tlemsani, et al.
Cancer Research|March 27, 2015
CDK2 Inhibition Causes Anaphase Catastrophe in Lung Cancer through the Centrosomal Protein CP110Shanhu Hu, Alexey V Danilov, Kristina Godek, et al.
Pageof 22